CPP Investments
CPP Investments is a professional investment management organization based in Toronto, Canada, established in 1997 to manage the assets of the Canada Pension Plan. Its primary mandate is to invest these assets in a manner that prioritizes the best interests of Canadian contributors and beneficiaries while seeking to maximize investment returns without exposing the fund to undue risk. The organization was created in response to demographic challenges that threatened the sustainability of the Canada Pension Plan, as fewer workers were supporting a growing number of retirees. CPP Investments diversifies its portfolio across various asset classes, including public equity, private equity, real estate, and infrastructure, to ensure long-term growth and stability for the pension fund.
Allete
Acquisition in 2024
ALLETE, Inc. is an energy company based in Duluth, Minnesota, incorporated in 1906. It operates through two primary segments: Regulated Operations and ALLETE Clean Energy. The Regulated Operations segment includes Minnesota Power and Superior Water, Light and Power Company, which provide electric, natural gas, and water services to a significant number of customers in northeastern Minnesota and northwestern Wisconsin. Additionally, this segment encompasses an investment in American Transmission Company, a utility that maintains electric transmission infrastructure across parts of Wisconsin, Michigan, Minnesota, and Illinois. ALLETE Clean Energy focuses on the development, acquisition, and operation of clean and renewable energy projects, operating around 660 megawatts of wind energy generation. The company is also involved in coal mining operations in North Dakota and real estate investments in Florida, while owning and operating multiple substations with substantial capacity.
Aldevron
Private Equity Round in 2019
Aldevron, LLC is a contract science organization based in Fargo, North Dakota, that specializes in the production of biological products, including plasmid DNA, proteins, antibodies, and nucleic acids. Founded in 1998, the company serves academic, research institutions, and the pharmaceutical and biotechnology sectors, focusing on applications in gene therapy and gene editing. Aldevron offers a range of services such as plasmid DNA production, protein production, antibody discovery, and mRNA production, as well as custom manufacturing solutions. Its products support various research and clinical applications, including DNA vaccines and therapeutic gene transfer studies. The company also provides additional services like gene synthesis, antibody processing, and stability services for distribution. Aldevron operates both in the United States and Europe, contributing to the development of innovative treatments for diseases, including cancer and rare disorders.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.